Maryland Department of Health - Forensic Review Board - Established
SB43 requires the Maryland Department of Health to establish forensic review boards at facilities that house people committed as not criminally responsible. These boards are authorized to review each committed person’s eligibility for release at least once a year, or sooner if the treatment team determines the person may be ready for discharge or conditional release. The boards may recommend discharge or conditional release to the court, must keep written records of their findings, and must consider statements from the committed person. The bill also sets notice requirements, allows a committed person to appoint an authorized agent to participate in board meetings, and directs the department to adopt regulations to implement the process.
The bill also creates a new Community Forensic Aftercare Program within the Department of Health to monitor committed persons who are conditionally released. The program is designed to follow the recommendations of the person’s mental health team, hold meetings at least every 90 days with the person and the treatment team, and respond to alleged violations of conditional release by making required notifications to the court and State’s Attorney. It also requires the program to provide records within 48 hours of a request unless disclosure is barred by law. The act takes effect October 1, 2025, and amends Maryland criminal procedure and health law provisions governing committed persons and conditional release.
The bill’s impact is to add a formal, statewide review structure for release decisions involving persons found not criminally responsible, while also creating a dedicated aftercare monitoring system for those on conditional release. It changes the responsibilities of the Maryland Department of Health, treatment teams, courts, and prosecutors by establishing new review, notice, documentation, and reporting procedures, and by requiring regulations to carry out the new framework. It also affects the rights and participation of committed persons by giving them notice, a chance to submit statements, and the ability to designate an authorized agent or advocate in certain proceedings.
The overall sentiment reflected in the voting history is strongly favorable and noncontroversial: the bill passed the Senate 42-0 and the House 135-0. No committee transcript excerpts were provided, so there is no recorded floor or committee debate to indicate opposition. The unanimous votes suggest broad bipartisan support for the bill’s structure and goals, likely reflecting a shared interest in improving oversight, rehabilitation planning, and public safety for this population.
The main points of potential contention, based on the bill text itself, would be the balance between patient rights and public safety, and the degree of access or participation allowed in forensic review board proceedings. The bill limits counsel’s attendance at board meetings while allowing an authorized agent to participate only by giving and hearing arguments, which could raise concerns about representation and due process. Another possible issue is the new monitoring and reporting obligations for conditionally released individuals, though the unanimous votes indicate these concerns did not generate visible opposition in the legislative process.
SB43 adds new provisions to the Criminal Procedure Article governing committed persons found not criminally responsible and creates a new subtitle in the Health-General Article for the Community Forensic Aftercare Program. It requires the Maryland Department of Health to establish forensic review boards, sets procedures for annual and expedited release reviews, and mandates recordkeeping, notice, and regulatory implementation. It also creates a statewide aftercare monitoring program for conditionally released committed persons, with reporting and records-access requirements that affect the Department, treatment teams, courts, State’s Attorneys, public defenders, and committed persons.
The bill appears to have enjoyed broad, unanimous support in both chambers, passing the Senate 42-0 and the House 135-0. With no committee transcript excerpts available, there is no documented floor or committee opposition in the provided materials. The voting record suggests the bill was viewed as a practical administrative and public-safety measure rather than a controversial policy change.
The most notable potential contention is the balance between clinical judgment, judicial oversight, and the rights of committed persons. The bill creates forensic review boards that can recommend discharge or conditional release, but it also limits who may attend board meetings and how representation works, which could raise due process concerns. The new aftercare program’s monitoring and reporting duties may also be seen as increasing supervision of conditionally released individuals, though the unanimous votes indicate these issues did not produce visible legislative conflict.